BlossomHill Therapeutics, Inc. BLSM
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -23.76M | -21.01M | -13.24M | ||
| Total Depreciation and Amortization | 125.00K | 125.00K | 102.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 976.00K | 648.00K | 557.00K | ||
| Change in Net Operating Assets | -577.00K | -705.00K | 3.44M | ||
| Cash from Operations | -23.23M | -20.94M | -9.14M | ||
| Capital Expenditure | 0.00 | -13.00K | -595.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | 0.00 | -13.00K | -595.00K | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 2.61M | 274.00K | 46.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 2.61M | 274.00K | 46.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -20.63M | -20.68M | -9.69M | ||